The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
The extracellular matrix as a cell survival factor.
Meredith, J. E., Fazeli, B., & Schwartz, M. A. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.9.953 · Cited by 1,526
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1996) · Nature · doi:10.1038/381713a0 · Cited by 728
Requirement of p27 Kip1 for Restriction Point Control of the Fibroblast Cell Cycle
Coats, S., Flanagan, W. M., Nourse, J., & Roberts, J. M. (1996) · Science · doi:10.1126/science.272.5263.877 · Cited by 679
Resistance to Apoptosis Conferred by Cdk Inhibitors During Myocyte Differentiation
Wang, J., & Walsh, K. (1996) · Science · doi:10.1126/science.273.5273.359 · Cited by 489
Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines
Wagner, R. W., Matteucci, M. D., Lewis, J. G., Gutierrez, A. J., Moulds, C., & Froehler, B. C. (1993) · Science · doi:10.1126/science.7684856 · Cited by 405
Absence of WAF1 mutations in a variety of human malignancies
Shiohara, M., el-Deiry, W., Wada, M., Nakamaki, T., Takeuchi, S., Yang, R., Chen, D., Vogelstein, B., & Koeffler, H. (1994) · Blood · doi:10.1182/blood.v84.11.3781.bloodjournal84113781 · Cited by 368
Dependence of Cyclin E-CDK2 Kinase Activity on Cell Anchorage
Fang, F., Orend, G., Watanabe, N., Hunter, T., & Ruoslahti, E. (1996) · Science · doi:10.1126/science.271.5248.499 · Cited by 361
Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
Teicher, B., Herman, T., Holden, S., Wang, Y., Pfeffer, M., Crawford, J., & Frei, E. (1990) · Science · doi:10.1126/science.247.4949.1457 · Cited by 327
Slingerland, J. M., Hengst, L., Pan, C. H., Alexander, D., Stampfer, M. R., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3683 · Cited by 324
Self-citationp27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
Ponce-Castañeda, M. V., Lee, M.-H., Latres, E., Polyák, K., Lacombe, L., Montgomery, K., Mathew, S., Krauter, K., Sheinfeld, J., & Massagué, J. (1995) · PubMed · Cited by 318
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata, N., Roberta Morosetti, A., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J. F., & Wilcyznski, S. (1995) · PubMed · Cited by 312
A cell cycle-regulated inhibitor of cyclin-dependent kinases.
Hengst, L., Dulic, V, Slingerland, J. M., Lees, E., & Reed, S. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5291 · Cited by 287
Self-citationAcquired multicellular-mediated resistance to alkylating agents in cancer.
Kobayashi, H., Man, S., Graham, C. H., Kapitain, S. J., Teicher, B. A., & Kerbel, R. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3294 · Cited by 278
Self-citationDrug and radiation resistance in spheroids: cell contact and kinetics
Olive, P. L., & Durand, R. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689632 · Cited by 270
Apoptosis induced by inhibition of intercellular contact.
Bates, R. C., Buret, A., van Helden, D. F., Horton, M. A., & Burns, G. F. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.2.403 · Cited by 248
Cell kinetics and chemotherapy: a critical review.
Tannock, I. F. (1978) · PubMed · Cited by 223
Poluha, W., Poluha, D. K., Chang, B., Crosbie, N. E., Schonhoff, C. M., Kilpatrick, D. L., & Ross, A. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1335 · Cited by 223
Repair of Potentially Lethal Radiation Damage In Vitro and In Vivo
Little, J. B., Hahn, G. M., Frindel, E., & Tubiana, M. (1973) · Radiology · doi:10.1148/106.3.689 · Cited by 194
p27/Kip1 mutation found in breast cancer.
Spirin, K. S., Simpson, J., Takeuchi, S., Kawamata, N., Cw, M., & Koeffler, H. P. (1996) · PubMed · Cited by 165
Croix, B. S., Rak, J. W., Kapitain, S. J., Sheehan, C., Graham, C. H., & Kerbel, R. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.18.1285 · Cited by 107
Self-citationMolecular foundations of cancer: New targets for intervention
Karp, J. E., & Broder, S. E. (1995) · Nature Medicine · doi:10.1038/nm0495-309 · Cited by 97
Zhang, W., Kornblau, S. M., Kobayashi, T., Gambel, A. M., Claxton, D. F., & Deisseroth, A. B. (1995) · PubMed · Cited by 93
Dimanche‐Boitrel, M., Pelletier, H., Genne, P., Petit, J., Grimellec, C. L., Canal, P., Ardiet, C. J., Bastian, G., & Chauffert, B. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500502 · Cited by 88
Ferrando, A., Balbı́n, M., Pendás, A. M., Vizoso, F. J., Velasco, G., & López-Otı́n, C. (1996) · Human Genetics · doi:10.1007/bf00218840 · Cited by 80
Kerbel, R. S., Rak, J., Kobayashi, H., Man, M. S., Croix, B. S., & Ch, G. (1994) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1994.059.01.076 · Cited by 64
Self-citationConte, P., Pronzato, P., RUBAGOTTI, A., Alama, A., Amadori, D., Demicheli, R., Gardin, G., Gentilini, P., Jacomuzzi, A., & Lionetto, R. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.3.339 · Cited by 62
New Drugs: Antisense Oligodeoxynucleotides as Clinical Therapeutic Agents
Tonkinson, J. L., & Stein, C. (1996) · Cancer Investigation · doi:10.3109/07357909609018436 · Cited by 44
The three-dimensional question: can clinically relevant tumor drug resistance be measuredin vitro?
Hoffman, R. M. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689634 · Cited by 28
Kinetic resistance to anticancer agents
Dimanche‐Boitrel, M., Garrido, C., & Chauffert, B. (1993) · Cytotechnology · doi:10.1007/bf00744672 · Cited by 28
Gore, S. D., Weng, L. J., Jones, R. J., Cowan, K., Zilcha, M., Piantadosi, S., & Burke, P. J. (1995) · PubMed · Cited by 16
Cited by
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
Ovarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154
Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., & Dalton, W. S. (1999) · Blood · doi:10.1182/blood.v93.5.1658 · Cited by 901
Environment-mediated drug resistance: A major contributor to minimal residual disease
Meads, M. B., Gatenby, R. A., & Dalton, W. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2714 · Cited by 892
Catzavelos, C., Bhattacharya, N., Ung, Y. C., Wilson, J. A., Roncari, L., Sandhu, C., Shaw, P., Yeger, H., Morava-Protzner, I., Kapusta, L., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-227 · Cited by 823
Self-citation
Metadata
- Authors
- Croix, B. S., Flørenes, V. A., Rak, J. W., Flanagan, M., Bhattacharya, N., Slingerland, J. M., & Kerbel, R. S.
- Venue
- Nature Medicine
- Published
- 1996-11
- Volume
- 2
- Issue
- 11
- Pages
- 1204-1210
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2089687291
- Cited by
- 322
- References
- 41
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.